{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T22:48:31Z","timestamp":1768085311667,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.prro.2019.05.012","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:38:45Z","timestamp":1559043525000},"page":"418-425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Salvage Curative-Intent Reirradiation Stereotactic Body Radiation Therapy for Isolated Pelvic and\/or Paraortic Recurrences of Gynecologic Malignancies"],"prefix":"10.1016","volume":"9","author":[{"given":"Diane C.","family":"Ling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Vargo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven A.","family":"Burton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dwight E.","family":"Heron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushil","family":"Beriwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2019.05.012_bib1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.6004\/jnccn.2019.0001","article-title":"Cervical Cancer, version 3.2019, NCCN clinical practice guidelines in oncology","volume":"17","author":"Koh","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.prro.2019.05.012_bib2","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1634\/theoncologist.2002-0342","article-title":"Guidelines for the treatment of recurrent and metastatic cervical cancer","volume":"7","author":"Friedlander","year":"2002","journal-title":"Oncologist"},{"key":"10.1016\/j.prro.2019.05.012_bib3","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1200\/JCO.2004.04.170","article-title":"Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: A gynecologic oncology group study","volume":"22","author":"Moore","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2019.05.012_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1748-717X-8-7","article-title":"Stereotactic body radiation therapy in the re-irradiation situation\u2014a review","volume":"8","author":"Mantel","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2019.05.012_bib5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/CCO.0000000000000392","article-title":"Re-irradiation of cervical and endometrial cancer","volume":"29","author":"Llewelyn","year":"2017","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.prro.2019.05.012_bib6","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/CCO.0b013e328363e0ad","article-title":"Role of stereotactic radiosurgery in gynecologic cancer","volume":"25","author":"Kunos","year":"2013","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.prro.2019.05.012_bib7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.4329\/wjr.v6.i6.366","article-title":"Use of stereotactic radiosurgery in the treatment of gynecologic malignancies: A review","volume":"6","author":"Long","year":"2014","journal-title":"World J Radiol"},{"key":"10.1016\/j.prro.2019.05.012_bib8","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1016\/j.prro.2014.10.013","article-title":"Extended field intensity modulated radiation for gynecologic cancers: Is the duodenal toxicity high?","volume":"5","author":"Xu","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2019.05.012_bib9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ijrobp.2013.09.053","article-title":"Dosimetric predictors of duodenal toxicity after intensity modulated radiation therapy for treatment of the para-aortic nodes in gynecologic cancer","volume":"88","author":"Verma","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2019.05.012_bib10","first-page":"5103","article-title":"Stereotactic body radiotherapy for recurrence or oligometastatic uterine cervix cancer: A cooperative study of the Korean Radiation Oncology Group (KROG 14-11)","volume":"35","author":"Park","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.prro.2019.05.012_bib11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/IGC.0000000000000869","article-title":"Clinical outcomes for stereotactic ablative radiotherapy in oligometastatic and oligoprogressive gynecological malignancies","volume":"27","author":"Mesko","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.prro.2019.05.012_bib12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijrobp.2008.07.020","article-title":"Image-guided stereotactic body radiation therapy in patients with isolated para-aortic lymph node metastases from uterine cervical and corpus cancer","volume":"74","author":"Choi","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2019.05.012_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fonc.2012.00181","article-title":"Phase II clinical trial of robotic stereotactic body radiosurgery for metastatic gynecologic malignancies","volume":"2","author":"Kunos","year":"2012","journal-title":"Front Oncol"},{"key":"10.1016\/j.prro.2019.05.012_bib14","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1097\/IGC.0000000000001324","article-title":"Stereotactic body radiation therapy in oligometastatic ovarian cancer: A promising therapeutic approach","volume":"28","author":"Iftode","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.prro.2019.05.012_bib15","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/IGC.0000000000000885","article-title":"Clinical outcomes of stereotactic body radiotherapy in oligometastatic gynecological cancer","volume":"27","author":"Laliscia","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.prro.2019.05.012_bib16","first-page":"415","article-title":"Stereotactic radiotherapy in recurrent gynecological cancer: A case series","volume":"22","author":"Deodato","year":"2009","journal-title":"Oncol Rep"},{"key":"10.1016\/j.prro.2019.05.012_bib17","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/cncr.29161","article-title":"Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma","volume":"121","author":"Herman","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2019.05.012_bib18","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/j.prro.2014.09.006","article-title":"Stereotactic body radiation therapy for abdominal and pelvic oligometastases: Dosimetric targets for safe and effective local control","volume":"5","author":"Rwigema","year":"2015","journal-title":"Prac Radiat Oncol"},{"key":"10.1016\/j.prro.2019.05.012_bib19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3389\/fonc.2015.00126","article-title":"Phase I trial of carboplatin and gemcitabine chemotherapy and stereotactic ablative radiosurgery for the palliative treatment of persistent or recurrent gynecologic cancer","volume":"5","author":"Kunos","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.prro.2019.05.012_bib20","doi-asserted-by":"crossref","unstructured":"Gomez DR, Tang C, Zhang J, et\u00a0al. Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: Long-term results of a multi-institutional, phase II, randomized study. J Clin Oncol. 2019;37:1558-1565.","DOI":"10.1200\/JCO.19.00201"},{"key":"10.1016\/j.prro.2019.05.012_bib21","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): A randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2019.05.012_bib22","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.prro.2012.03.013","article-title":"Intensity modulated radiation therapy for definitive treatment of paraaortic relapse in patients with endometrial cancer","volume":"3","author":"Shirvani","year":"2013","journal-title":"Practical Radiation Oncology"},{"key":"10.1016\/j.prro.2019.05.012_bib23","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ygyno.2018.12.022","article-title":"Outcomes after definitive re-irradiation with 3D brachytherapy with or without external beam radiation therapy for vaginal recurrence of endometrial cancer","volume":"152","author":"Ling","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2019.05.012_bib24","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/IGC.0000000000000884","article-title":"Survival after pelvic exenteration for cervical cancer: A national cancer database study","volume":"27","author":"Graves","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.prro.2019.05.012_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.radonc.2014.11.021","article-title":"Reirradiation of locally recurrent rectal cancer: A systemic review","volume":"113","author":"Guren","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2019.05.012_bib26","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJMoa1309748","article-title":"Improved survival with bevacizumab in advanced cervical cancer","volume":"370","author":"Tewari","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2019.05.012_bib27","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijrobp.2015.02.016","article-title":"Gastrointestinal toxicities with combined antiangiogenic and stereotactic body radiation therapy","volume":"92","author":"Pollom","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2019.05.012_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijrobp.2013.05.012","article-title":"Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT)","volume":"87","author":"Barney","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850019301584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850019301584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:22:01Z","timestamp":1761819721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850019301584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1879850019301584"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2019.05.012","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salvage Curative-Intent Reirradiation Stereotactic Body Radiation Therapy for Isolated Pelvic and\/or Paraortic Recurrences of Gynecologic Malignancies","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2019.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}